Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR
Motley Fool
Tue, 01/28/20 - 12:04 pm
Tags:
FDA, Eli Lilly, Boehringer Ingelheim, Trijardy XR, Jardiance, Tradjenta, metformin, diabetes
Eli Lilly Donates Insulin KwikPens to Support Free Clinics in the U.S.
BioSpace
Tue, 01/28/20 - 11:53 am
Tags:
Eli Lilly, insulin, diabetes, KwikPens, philanthropy
Addition of Pegilodecakin to FOLFOX Did Not Improve OS in Metastatic Pancreatic Cancer
Cancer Therapy Advisor
Fri, 01/24/20 - 12:05 am
Tags:
Eli Lilly, pegilodecakin, pancreatic cancer, clinical trials, metastatic pancreatic cancer
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
Wed, 01/22/20 - 11:06 am
Tags:
earnings, Novartis, Biogen, Eli Lilly, Global Blood Therapeutics, Bluebird Bio
Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased
Endpoints
Tue, 01/21/20 - 11:44 pm
Tags:
Eli Lilly, drug manufacturing, North Carolina, hirings
What Does the Future Hold for Nextcure?
Motley Fool
Sat, 01/18/20 - 07:30 pm
Tags:
NextCure, Eli Lilly, oncology
With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans
BioSpace
Wed, 01/15/20 - 10:59 am
Tags:
drug pricing, Roche, Eli Lilly, Amgen, Alnylam, Sanofi
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Motley Fool
Tue, 01/14/20 - 10:07 pm
Tags:
Eli Lilly, generics, insulin, diabetes, Lispro
Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads
Fierce Pharma
Mon, 01/13/20 - 10:47 am
Tags:
Merck, Eli Lilly, Amgen, HHS, drug pricing, television ads
Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion
BioSpace
Fri, 01/10/20 - 10:43 am
Tags:
Eli Lilly, Dermira, dermatology, M&A, atopic dermatitis
Lilly, Strateos open remote-controlled robotic research lab in San Diego
BioPharma Dive
Thu, 01/9/20 - 11:58 pm
Tags:
Eli Lilly, Strateos, robotics, San Diego
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
Tags:
M&A, AbbVie, Allergan, Astellas, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Lilly claims another victory in Alimta patent defence
Pharmaforum
Thu, 01/2/20 - 10:36 am
Tags:
Eli Lilly, Alimta, patents, generics
Is there a future for pharma in neuro?
Fierce Biotech
Sun, 12/22/19 - 12:25 am
Tags:
Neuroscience, R&D, Eli Lilly, Amgen, GSK, Novartis
After 'nonsense' retort, Lilly CEO urges patients to seek its help affording insulin
Fierce Pharma
Thu, 12/19/19 - 11:09 pm
Tags:
Eli Lilly, David Ricks, Pharma CEOs, insulin, patients, diabetes
Lilly launches real-world study to benchmark Emgality against migraine rivals
Fierce Pharma
Wed, 12/18/19 - 11:54 pm
Tags:
Eli Lilly, migraines, Emgality, real world evidence, RWE
Chuffed on new launches, Eli Lilly unveils Street-beating 2020 sales forecast
Fierce Pharma
Tue, 12/17/19 - 09:25 pm
Tags:
Eli Lilly
Lilly doubles down on Dexcom tech for connected insulin devices
Pharmaforum
Tue, 12/17/19 - 10:24 am
Tags:
Eli Lilly, DexCom, continuous glucose monitoring, devices, diabetes
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Mon, 12/16/19 - 10:35 am
Tags:
Jardiance, Eli Lilly, Boehringer Ingelheim, type 2 diabetes, chronic heart failure, clinical trials
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Fri, 12/13/19 - 09:05 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, Farxiga, diabetes, AstraZeneca, heart failure

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.